mitoXANTRONE

NDC 71288-178 · Meitheal Pharmaceuticals Inc.

Generic namemitoXANTRONE

Dosage formINJECTION, SOLUTION, CONCENTRATE

RouteINTRAVENOUS

Active ingredient(s)MITOXANTRONE HYDROCHLORIDE

Strength2 mg/mL

Pharmacologic classTopoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]

Marketing categoryANDA

Packages

71288-178-10 — 1 VIAL, MULTI-DOSE in 1 CARTON (71288-178-10) / 10 mL in 1 VIAL, MULTI-DOSE

Billed under HCPCS

J9293 — Injection, mitoxantrone hydrochloride, per 5 mg Medicare Part B payment limit (ASP + 6%): $19.42

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

61703-343 — Mitoxantrone, 63323-132 — MITOXANTRONE HYDROCHLORIDE, 71288-179 — mitoXANTRONE

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources